Arkstone OneChoice®, in the words of the customers who use it
KLAS independently interviewed Arkstone customers about how OneChoice turns complex pathogen and resistance data into clear, patient-specific treatment guidance. Here is what they reported.
What KLAS found
89.1*
Overall performance score
A*
Likelihood to recommend
A*
Customer support
14
Customer organizations interviewed
*Limited data per KLAS Emerging Company Spotlight methodology (n=14). Scores reflect early customer feedback and may change as additional organizations are interviewed.
What customers told KLAS
Built for clarity at the point of care
Interviewed customers described OneChoice as a clear, client-centered solution that simplifies complex lab data into guidance their providers can act on.
User-friendly interface
Customers sign in and start using OneChoice with little to no training. Reports are clean, readable, and designed for use at the point of care.
Clear, actionable reporting
OneChoice distills culture and molecular results into a primary recommendation plus ranked alternatives, so clinicians are not left interpreting complex resistance data on their own.
Responsive support
Customers repeatedly praised the Arkstone team as available, knowledgeable, and quick to resolve issues, describing the partnership as a genuine strength.
The key strength of OneChoice is that it provides a very clear report that is easy to understand.
— CEO/President, KLAS Emerging Company Spotlight, May 2026
About the spotlight
KLAS Research is one of healthcare’s most trusted sources of independent vendor evaluation. Emerging Company Spotlight reports capture verified customer experience with newer solutions, drawn from direct interviews rather than vendor claims.
OneChoice® is Arkstone’s clinical decision-support report for infectious disease. It combines machine learning with expert-in-the-loop clinical oversight to read diagnostic results and return precise, guideline-aligned, patient-specific guidance, supporting the clinician’s decision rather than replacing it.
See why KLAS spotlighted OneChoice
Book a short walkthrough and see the reports your clinicians would receive.
